alexa Sam Haidar | OMICS International
ISSN: 2155-9872

Journal of Analytical & Bioanalytical Techniques
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences
Share This Page

Sam Haidar

Director (Acting), Division of Generic Drug Bioequivalence Eval, Office of Study Integ & Surveillance, US FDA.

Biography

Sam Haidar completed his  Bachelor's Degree, Pharmacy  from University of Maryland Baltimore in the year  1992 and Ph.D., in  Pharmaceutical Science (Pharmacokinetics and Pharmacodynamics) from University of Maryland Baltimore in 1997. In the past he worked  as Lead Pharmacologist for USFDA, Currently he is working as Director (Acting), Division of Generic Drug Bioequivalence Eval, Office of Study Integ & Surveillancein USFDA.

Research Interest

His topics of research interests are Clinical Development, Regulatory Affairs, IND, Drug Discovery, Regulatory Submissions

Top